
- Highly statistically significant result observed on primary endpoint with a Win Ratio of 1.8 (p
On 6ix: 6ix.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of

- Highly statistically significant result observed on primary endpoint with a Win Ratio of 1.8 (p
Follow BridgeBio Pharma into a list and get an email when it puts out news.
Follow BridgeBio Pharma